長期投資家のためのIR情報
バリュートレンド

【4556】カイノス 〔上場廃止〕
ー(上場廃止)臨床検査薬。
類似企業:
【業界1位】 小野薬品工業
【売上同水準】 大幸薬品 セルソース

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.03 2026/05/08 実 5,479 ↓ -0.4% -0.4% 747 ↓ -12.1% -12.1% 788 ↓ -7.3% -7.3% 449 ↓ -25.2% -25.2%
2026.03 2026/01/27 Q3予 5,500 → 0.0% 0.0% 850 → 0.0% 0.0% 850 → 0.0% 0.0% 600 → 0.0% 0.0%
2026.03 2025/10/28 Q2予 5,500 → 0.0% 0.0% 850 → 0.0% 0.0% 850 → 0.0% 0.0% 600 → 0.0% 0.0%
2026.03 2025/07/25 Q1予 5,500 → 0.0% 0.0% 850 → 0.0% 0.0% 850 → 0.0% 0.0% 600 → 0.0% 0.0%
2026.03 2025/05/09 当初予 5,500 - - - 850 - - - 850 - - - 600 - - -
2025.03 2025/05/09 実 5,305 ↓ -1.8% -1.8% 823 ↑ +2.9% +2.9% 828 ↑ +3.5% +3.5% 641 ↑ +16.5% +16.5%
2025.03 2025/01/24 Q3予 5,400 → 0.0% 0.0% 800 → 0.0% 0.0% 800 → 0.0% 0.0% 550 → 0.0% 0.0%
2025.03 2024/10/25 Q2予 5,400 → 0.0% 0.0% 800 → 0.0% 0.0% 800 → 0.0% 0.0% 550 → 0.0% 0.0%
2025.03 2024/07/25 Q1予 5,400 → 0.0% 0.0% 800 → 0.0% 0.0% 800 → 0.0% 0.0% 550 → 0.0% 0.0%
2025.03 2024/05/09 当初予 5,400 - - - 800 - - - 800 - - - 550 - - -
2024.03 2024/05/09 実 5,056 ↓ -2.8% -2.8% 865 ↑ +1.8% +1.8% 928 ↑ +9.2% +9.2% 637 ↑ +11.8% +11.8%
2024.03 2024/01/25 Q3予 5,200 → 0.0% 0.0% 850 → 0.0% 0.0% 850 → 0.0% 0.0% 570 → 0.0% 0.0%
2024.03 2023/10/25 Q2予 5,200 → 0.0% 0.0% 850 → 0.0% 0.0% 850 → 0.0% 0.0% 570 → 0.0% 0.0%
2024.03 2023/07/25 Q1予 5,200 → 0.0% 0.0% 850 → 0.0% 0.0% 850 → 0.0% 0.0% 570 → 0.0% 0.0%
2024.03 2023/05/10 当初予 5,200 - - - 850 - - - 850 - - - 570 - - -
2023.03 2023/05/10 実 4,923 ↓ -3.5% -1.5% 821 ↓ -8.8% +2.6% 853 ↓ -5.2% +6.6% 568 ↓ -5.3% +9.2%
2023.03 2023/01/25 Q3予 5,100 → 0.0% +2.0% 900 → 0.0% +12.5% 900 → 0.0% +12.5% 600 → 0.0% +15.4%
2023.03 2022/10/25 Q2予 5,100 → 0.0% +2.0% 900 → 0.0% +12.5% 900 → 0.0% +12.5% 600 → 0.0% +15.4%
2023.03 2022/10/13 修正予 5,100 ↑ +2.0% +2.0% 900 ↑ +12.5% +12.5% 900 ↑ +12.5% +12.5% 600 ↑ +15.4% +15.4%
2023.03 2022/07/25 Q1予 5,000 → 0.0% 0.0% 800 → 0.0% 0.0% 800 → 0.0% 0.0% 520 → 0.0% 0.0%
2023.03 2022/05/09 当初予 5,000 - - - 800 - - - 800 - - - 520 - - -
2022.03 2022/05/09 実 4,614 ↓ -3.9% +0.3% 747 ↓ -6.6% +24.5% 777 ↓ -2.9% +29.5% 512 ↓ -5.2% +28.0%
2022.03 2022/01/25 Q3予 4,800 → 0.0% +4.3% 800 → 0.0% +33.3% 800 → 0.0% +33.3% 540 → 0.0% +35.0%
2022.03 2021/10/26 Q2予 4,800 → 0.0% +4.3% 800 → 0.0% +33.3% 800 → 0.0% +33.3% 540 → 0.0% +35.0%
2022.03 2021/09/27 修正予 4,800 ↑ +4.3% +4.3% 800 ↑ +33.3% +33.3% 800 ↑ +33.3% +33.3% 540 ↑ +35.0% +35.0%
2022.03 2021/07/26 Q1予 4,600 → 0.0% 0.0% 600 → 0.0% 0.0% 600 → 0.0% 0.0% 400 → 0.0% 0.0%
2022.03 2021/05/07 当初予 4,600 - - - 600 - - - 600 - - - 400 - - -
2021.03 2021/05/07 実 4,257 ↓ -5.4% -5.4% 632 ↓ -2.8% +40.4% 653 ↑ +0.5% +45.1% 417 ↓ -7.3% +39.0%
2021.03 2021/01/25 Q3予 4,500 → 0.0% 0.0% 650 → 0.0% +44.4% 650 → 0.0% +44.4% 450 → 0.0% +50.0%
2021.03 2020/10/26 修正予 4,500 → 0.0% 0.0% 650 ↑ +44.4% +44.4% 650 ↑ +44.4% +44.4% 450 ↑ +50.0% +50.0%
2021.03 2020/07/27 Q1予 4,500 → 0.0% 0.0% 450 → 0.0% 0.0% 450 → 0.0% 0.0% 300 → 0.0% 0.0%
2021.03 2020/05/08 当初予 4,500 - - - 450 - - - 450 - - - 300 - - -
2020.03 2020/05/08 実 4,609 ↓ -7.8% -7.8% 608 ↓ -6.5% +10.5% 616 ↓ -5.2% +12.0% 398 ↓ -11.6% +4.7%
2020.03 2020/01/24 修正予 5,000 → 0.0% 0.0% 650 ↑ +18.2% +18.2% 650 ↑ +18.2% +18.2% 450 ↑ +18.4% +18.4%
2020.03 2019/10/25 Q2予 5,000 → 0.0% 0.0% 550 → 0.0% 0.0% 550 → 0.0% 0.0% 380 → 0.0% 0.0%
2020.03 2019/07/25 Q1予 5,000 → 0.0% 0.0% 550 → 0.0% 0.0% 550 → 0.0% 0.0% 380 → 0.0% 0.0%
2020.03 2019/05/08 当初予 5,000 - - - 550 - - - 550 - - - 380 - - -
2019.03 2019/05/08 実 4,670 ↓ -2.7% -0.6% 581 ↑ +16.2% +45.2% 596 ↑ +19.2% +49.0% 385 ↑ +10.0% +37.5%
2019.03 2019/01/25 Q3予 4,800 → 0.0% +2.1% 500 → 0.0% +25.0% 500 → 0.0% +25.0% 350 → 0.0% +25.0%
2019.03 2018/10/25 Q2予 4,800 → 0.0% +2.1% 500 → 0.0% +25.0% 500 → 0.0% +25.0% 350 → 0.0% +25.0%
2019.03 2018/09/25 修正予 4,800 ↑ +2.1% +2.1% 500 ↑ +25.0% +25.0% 500 ↑ +25.0% +25.0% 350 ↑ +25.0% +25.0%
2019.03 2018/07/25 Q1予 4,700 → 0.0% 0.0% 400 - - - 400 → 0.0% 0.0% 280 → 0.0% 0.0%
2019.03 2018/05/09 当初予 4,700 - - - - - - - 400 - - - 280 - - -
2018.03 2018/05/09 実 - - - - - - - - - - - - - - - -
2018.03 2018/01/25 Q3予 4,600 → 0.0% 0.0% 420 ↑ +20.0% +20.0% 440 ↑ +29.4% +29.4% 260 ↑ +10.6% +10.6%
2018.03 2017/10/25 Q2予 4,600 → 0.0% 0.0% 350 → 0.0% 0.0% 340 → 0.0% 0.0% 235 → 0.0% 0.0%
2018.03 2017/07/25 Q1予 4,600 → 0.0% 0.0% 350 → 0.0% 0.0% 340 → 0.0% 0.0% 235 → 0.0% 0.0%
2018.03 2017/05/10 当初予 4,600 - - - 350 - - - 340 - - - 235 - - -
2017.03 2017/05/10 実 4,703 ↓ -7.5% -7.5% 474 ↑ +3.0% +3.0% 468 ↑ +3.8% +3.8% 309 ↓ -3.4% -3.4%
2017.03 2017/01/25 Q3予 5,083 → 0.0% 0.0% 460 → 0.0% 0.0% 451 → 0.0% 0.0% 320 → 0.0% 0.0%
2017.03 2016/05/10 当初予 5,083 - - - 460 - - - 451 - - - 320 - - -
2016.03 2016/05/10 実 5,345 ↑ +0.8% -7.8% 442 ↑ +7.8% +3.3% 440 ↑ +6.5% +0.7% 296 ↑ +5.7% +2.8%
2016.03 2016/01/25 Q3予 5,300 → 0.0% -8.6% 410 → 0.0% -4.2% 413 → 0.0% -5.5% 280 → 0.0% -2.8%
2016.03 2015/10/26 修正予 5,300 ↓ -8.6% -8.6% 410 ↓ -4.2% -4.2% 413 ↓ -5.5% -5.5% 280 ↓ -2.8% -2.8%
2016.03 2015/07/24 Q1予 5,800 → 0.0% 0.0% 428 → 0.0% 0.0% 437 → 0.0% 0.0% 288 → 0.0% 0.0%
2016.03 2015/05/08 当初予 5,800 - - - 428 - - - 437 - - - 288 - - -
2015.03 2015/05/08 実 5,476 ↓ -8.7% -8.7% 401 ↑ +21.5% +21.5% 392 ↑ +24.4% +24.4% 230 ↑ +15.0% +15.0%
2015.03 2015/01/26 Q3予 6,000 → 0.0% 0.0% 330 → 0.0% 0.0% 315 → 0.0% 0.0% 200 → 0.0% 0.0%
2015.03 2014/10/24 Q2予 6,000 → 0.0% 0.0% 330 → 0.0% 0.0% 315 → 0.0% 0.0% 200 → 0.0% 0.0%
2015.03 2014/07/25 Q1予 6,000 → 0.0% 0.0% 330 → 0.0% 0.0% 315 → 0.0% 0.0% 200 → 0.0% 0.0%
2015.03 2014/05/09 当初予 6,000 - - - 330 - - - 315 - - - 200 - - -
2014.03 2014/05/09 実 5,803 - - - 318 - - - 314 - - - 193 - - -
シェア ツイート
ページトップへ戻る